UNSPSC 85642141: Revision of nonautologous tissue substitute in lower extremity subcutaneous tissue and fascia, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of nonautologous tissue substitute in lower extremity subcutaneous tissue and fascia, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0JWW3KZ

UNSPSC 85642141 Revision of nonautologous tissue substitute in lower extremity subcutaneous tissue and fascia, percutaneous approach is a Commodity code with minimal alignment to recent state and local procurement activity. The code's clinical procedure nomenclature does not correspond to the work actually being solicited under it by state and local issuing bodies. Recent opportunities tagged to this code span occupational medical surveillance, disability pension medical evaluations, surgical benefit carve-outs for employee health plans, pharmacy benefit management, temporary health professional staffing, emergency medical services for youth in custody, and specialty medical networks—none of which involve tissue substitute revision procedures or tissue engineering in the orthopedic or reconstructive surgery domain the code nominally describes.

The recent-opportunities dataset shows activity from Arizona (City of Phoenix Retirement Office), California (City of Long Beach, County of Santa Clara Health System), Washington State (Department of Transportation), Texas (Harris County Juvenile Probation Department), and Florida (Collier County Board of County Commissioners), with issuing bodies spanning city retirement offices, county health systems, state transportation departments, county human resources divisions, and county probation departments. The code appears to carry substantial tagging misalignment across these diverse jurisdictions and use cases, suggesting the code is either systematically miscoded in state and local procurement systems or serves as a catch-all placeholder for medical services procurement rather than a true commodity classifier for tissue substitute procedures. No recent opportunities reflect the actual clinical and product scope the code name describes.